{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-002460","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2023-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.725622+00:00","generated_at":"2026-06-16T18:56:16.350985+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Corvus Pharmaceuticals regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq deficiency notice on Oct 25, 2022 for bid price below $1.00.","Compliance period was 180 days, expiring April 24, 2023.","On April 21, 2023, Nasdaq confirmed compliance after 10 consecutive business days of closing bid price at or above $1.00 from April 6-20.","Matter is now closed; no further action needed on listing requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-002460","json":"https://secwatch.observer/filing/0001171843-23-002460.json","markdown":"https://secwatch.observer/filing/0001171843-23-002460.md","text":"https://secwatch.observer/filing/0001171843-23-002460.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323002460/0001171843-23-002460-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184323002460/f8k_042423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T18:56:16.350985+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}